Groenewegen A et al (2020) Epidemiology of heart failure. Eur J Heart Fail 22(8):1342–1356

Article  PubMed  Google Scholar 

Steinberg BA et al (2012) Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation 126(1):65–75

Article  PubMed  Google Scholar 

Beghini A et al. (2024) 2024 update in heart failure. ESC Heart Fail. https://doi.org/10.1002/ehf2.14857

McDonagh TA et al (2023) Focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 44(37):3627–3639

Article  CAS  PubMed  Google Scholar 

Koratala A, Kazory A (2017) Natriuretic peptides as biomarkers for congestive states: the cardiorenal divergence. Dis Markers 2017:1454986

Article  PubMed  PubMed Central  Google Scholar 

Yoo BS (2014) Clinical significance of B-type natriuretic peptide in Heart failure. J Lifestyle Med 4(1):34–38

Article  PubMed  PubMed Central  Google Scholar 

Harrison A et al (2002) B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med 39(2):131–138

Article  PubMed  Google Scholar 

Moher D et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535

Article  PubMed  PubMed Central  Google Scholar 

Akiyama E et al (2012) Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction. J Am Coll Cardiol 60(18):1778–1786

Article  PubMed  Google Scholar 

Beltrami M et al (2016) Additional value of Galectin-3 to BNP in acute heart failure patients with preserved ejection fraction. Clin Chim Acta 457:99–105

Article  CAS  PubMed  Google Scholar 

Izumiya Y et al (2014) Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction. Can J Cardiol 30(3):338–344

Article  PubMed  Google Scholar 

Kitada S et al (2018) The prognostic value of brain natriuretic peptide in patients with heart failure and left ventricular ejection fraction higher than 60%: a sub-analysis of the J-MELODIC study. ESC Heart Fail 5(1):36–45

Article  PubMed  Google Scholar 

Kimura Y et al (2016) High serum levels of thrombospondin-2 correlate with poor prognosis of patients with heart failure with preserved ejection fraction. Heart Vessels 31(1):52–59

Article  PubMed  Google Scholar 

Matsubara J et al (2014) Incremental prognostic significance of the elevated levels of pentraxin 3 in patients with heart failure with normal left ventricular ejection fraction. J Am Heart Assoc 3(4):e000928

Nakada Y et al (2016) Sex differences in clinical characteristics and long-term outcome in acute decompensated heart failure patients with preserved and reduced ejection fraction. Am J Physiol Heart Circ Physiol 310(7):H813–H820

Article  PubMed  Google Scholar 

Ohtani T et al (2012) Diastolic stiffness as assessed by diastolic wall strain is associated with adverse remodelling and poor outcomes in heart failure with preserved ejection fraction. Eur Heart J 33(14):1742–1749

Article  PubMed  PubMed Central  Google Scholar 

Schelbert EB et al (2017) Temporal relation between myocardial fibrosis and heart failure with preserved Ejection Fraction: Association with Baseline Disease Severity and subsequent outcome. JAMA Cardiol 2(9):995–1006

Article  PubMed  PubMed Central  Google Scholar 

Stavrakis S et al (2013) Obesity, brain natriuretic peptide levels and mortality in patients hospitalized with heart failure and preserved left ventricular systolic function. Am J Med Sci 345(3):211–217

Article  PubMed  Google Scholar 

French B et al (2016) Prognostic value of Galectin-3 for adverse outcomes in chronic heart failure. J Card Fail 22(4):256–262

Article  CAS  PubMed  Google Scholar 

Sobue Y et al (2018) Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF). Heart Vessels 33(4):403–412

Article  PubMed  Google Scholar 

Anjan VY et al (2012) Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction. Am J Cardiol 110(6):870–876

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kasahara S et al (2018) Comparable prognostic impact of BNP levels among HFpEF, Borderline HFpEF and HFrEF: a report from the CHART-2 study. Heart Vessels 33(9):997–1007

Article  PubMed  Google Scholar 

Meijers WC et al (2016) Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides. Neth Heart J 24(4):287–295

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thawabi M et al (2017) Cardiac troponin and outcome in decompensated heart failure with preserved ejection fraction. Cardiovasc Diagn Ther 7(4):359–366

Article  PubMed  PubMed Central  Google Scholar 

Sakane K et al (2021) Disproportionately low BNP levels in patients of acute heart failure with preserved vs. reduced ejection fraction. Int J Cardiol 327:105–110

Article  PubMed  Google Scholar 

Myhre PL et al (2022) Influence of NT-proBNP on efficacy of Dapagliflozin in Heart failure with mildly reduced or preserved ejection fraction. JACC Heart Fail 10(12):902–913

Article  CAS  PubMed  Google Scholar 

Chen YY et al (2023) Clinical characteristics and outcomes of patients hospitalized with heart failure with preserved ejection fraction and low NT-proBNP levels. Med (Baltim) 102(47):e36351

Article  CAS  Google Scholar 

Anand IS et al (2011) Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial. Circ Heart Fail 4(5):569–577

Article  CAS  PubMed  Google Scholar 

Cleland JG et al (2012) Relationship between plasma concentrations of N-terminal pro brain natriuretic peptide and the characteristics and outcome of patients with a clinical diagnosis of diastolic heart failure: a report from the PEP-CHF study. Eur J Heart Fail 14(5):487–494

Article  CAS  PubMed  Google Scholar 

Verbrugge FH et al (2022) Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality. Eur Heart J 43(20):1941–1951

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maisel AS et al (2003) Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing not properly multinational study. J Am Coll Cardiol 41(11):2010–2017

Article  PubMed  Google Scholar 

Clerico A et al (2018) Obese phenotype and natriuretic peptides in patients with heart failure with preserved ejection fraction. Clin Chem Lab Med 56(7):1015–1025

Article  CAS  PubMed  Google Scholar 

Melenovsky V et al (2014) Right heart dysfunction in heart failure with preserved ejection fraction. Eur Heart J 35(48):3452–3462

Article  CAS  PubMed  PubMed Central  Google Scholar